AGP Picks
View all

Informing on science news in the world

Provided by AGP

Science Press Releases
Got News to Share?
Got News to Share? globe Explore more publications!

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 18, 2026

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
May 18, 2026

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire
AvePoint to Participate in Upcoming Investor Conferences 
May 18, 2026

AvePoint to Participate in Upcoming Investor Conferences 

Indeterminate GlobeNewswire
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference
May 18, 2026

Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference

Indeterminate GlobeNewswire
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
May 18, 2026

Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland

Indeterminate GlobeNewswire
DeGen Medical Expands Patient-Specific Spine Platform
May 18, 2026

DeGen Medical Expands Patient-Specific Spine Platform

Indeterminate GlobeNewswire
project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion
May 18, 2026

project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion

Indeterminate GlobeNewswire
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  
May 18, 2026

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  

Indeterminate GlobeNewswire
Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT
May 18, 2026

Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT

Indeterminate GlobeNewswire
Utility Global Launches European Market Expansion at World Hydrogen Summit 2026
May 18, 2026

Utility Global Launches European Market Expansion at World Hydrogen Summit 2026

Indeterminate EIN Presswire
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
May 18, 2026

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

Indeterminate GlobeNewswire
Advancing Open Source Patent Protection: Preservation of OIN 2.0 Source Code
May 18, 2026

Advancing Open Source Patent Protection: Preservation of OIN 2.0 Source Code

Indeterminate GlobeNewswire
J.P. Morgan brings ‘Acquired’ Podcast hosts to the main stage at WeAreDevelopers World Congress North America
May 18, 2026

J.P. Morgan brings ‘Acquired’ Podcast hosts to the main stage at WeAreDevelopers World Congress North America

Indeterminate GlobeNewswire
Innosphere Announces 2026 Life Sciences Incubator Cohort
May 18, 2026

Innosphere Announces 2026 Life Sciences Incubator Cohort

Indeterminate GlobeNewswire
ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security
May 18, 2026

ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security

Indeterminate EIN Presswire
Funds Coin Expands AI Trading Infrastructure Across Gold, Forex, and Stock Markets With Multi-Agent Trading Systems
May 18, 2026

Funds Coin Expands AI Trading Infrastructure Across Gold, Forex, and Stock Markets With Multi-Agent Trading Systems

Indeterminate GlobeNewswire
AIOMEGA's Pediatric and Adult AIO Breathe® to feature AAVOAT™ and TAVMLR® Mechanistic Insights at SLEEP 2026 Baltimore
May 18, 2026

AIOMEGA's Pediatric and Adult AIO Breathe® to feature AAVOAT™ and TAVMLR® Mechanistic Insights at SLEEP 2026 Baltimore

Indeterminate EIN Presswire
Chinese Neurosurgical Journal Article Finds That Flow Diversion Devices are Exceptionally Safe
May 18, 2026

Chinese Neurosurgical Journal Article Finds That Flow Diversion Devices are Exceptionally Safe

Indeterminate EIN Presswire
Butyrate Relieves Temporomandibular Joint Pain Through Epigenetic Regulation
May 18, 2026

Butyrate Relieves Temporomandibular Joint Pain Through Epigenetic Regulation

Indeterminate EIN Presswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.